
Striking the right balance between work and freedom
The coronavirus pandemic has prompted us to rethink how we work in so many ways, including where we work — whether …
May 11, 2021: -EU leaders doubt that they are waiving intellectual property rights for Covid-19 vaccines, a proposal supported by the United States.
“It is not a matter of intellectual property rights. You can give the intellectual to labs that do not know how to produce the vaccinations, and they won’t be able to produce it overnight,” French President Emmanuel Macron said on Friday, according to a CNBC translation.
Meanwhile, German Chancellor Angela Merkel also said, “I made clear that I don’t believe that releasing the patents is the solution to provide vaccines for people.”
On Friday, Spanish Prime Minister Pedro Sanchez welcomed the U.S. decision to back vaccine patent waivers.
“It is a good initiative, but It might not be enough,” he said in Porto, Portugal, while advocating for production and distribution also to be scaled up.
Joe Biden gave a surprise to his European counterparts last week by announcing the U.S. administration favored lifting IP rights for Covid vaccines, citing the pandemic’s “extraordinary circumstances” of the pandemic.
Health experts, human rights groups, and international medical charities debate that it is critical to waiving IP rights to urgently address global vaccine scarcity between the pandemic and avoid prolonging the health crisis. However, Vaccine makers say this could disrupt the flow of raw materials while also leading to lower investments in health research from smaller biotech innovators.
France’s Macron insists that the best way to raise global vaccination rates is for vaccine-producing nations to increase exports.
“Today, the Anglo-Saxons are blocking a lot of these ingredients and vaccines. Currently, 100% of U.S produced vaccines of America go to the market of America,” he said.
The U.S. does not have an outright ban on exports of Covid shots. Still, it uses legislation to ensure that vaccines produced in the country are only sent abroad when established that there are sufficient doses to inoculate the American population.
The recent data from the European Commission, the executive arm of the EU, shows that out of the 400 million shots produced in the bloc so far, 200 million have been exported to 90 nations different.
European Commission President Ursula von der Leyen also said that exporting vaccines “is the best way right now, in the short term, to approach the bottlenecks and the lack vaccines worldwide.”
The coronavirus pandemic has prompted us to rethink how we work in so many ways, including where we work — whether …
Many countries are now welcoming employees back to work after a long period of uncertainty caused by the …
People who have an entrepreneurial mindset learn to spot new opportunities and create value inside a business naturally and …
COVID-19 has made routine modern-day disruptions for businesses even more challenging, impacting everything …
Innovations must be unconventional and ought to push boundaries. Innovation-driven people are …
COVID-19 changed the corporate environment in the blink of an eye, highlighting a vital, often misunderstood truth: that to …
July 5, 2022: -In the previous month, inflation in Turkey increased close to 79%, the country’s tallest in a quarter …
July 5, 2022: -Germany’s road traffic agency determined Tesla models Y and three because of a fault in the automatic …
July 5, 2022: -On Monday, the company said that Crypto lender Vauld halted all withdrawals, trading, and warranties …
June 30, 2022: -On Tuesday, NATO Secretary-General Jens Stoltenberg said that the most powerful military alliance …
Leave us a message
Subscribe
Fill the form our team will contact you
Advertise with us
Fill the form our team will contact you